LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Search

Evolent Health Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

4.15 3.49

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.94

Max

4.16

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

-21M

Pardavimai

35M

480M

Pelno marža

-4.351

Darbuotojai

4,500

EBITDA

512K

15M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+152.24% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-302M

478M

Ankstesnė atidarymo kaina

0.66

Ankstesnė uždarymo kaina

4.15

Naujienos nuotaikos

By Acuity

40%

60%

140 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-22 23:54; UTC

Pagrindinės rinkos jėgos

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

2025-12-22 19:08; UTC

Įsigijimai, susijungimai, perėmimai

Correction to Alphabet to Buy Intersect Article

2025-12-22 17:21; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

2025-12-22 16:46; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion in Cash

2025-12-22 23:50; UTC

Rinkos pokalbiai

Nikkei May Decline as Yen Rebounds -- Market Talk

2025-12-22 23:42; UTC

Rinkos pokalbiai

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

2025-12-22 22:30; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

2025-12-22 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-22 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

2025-12-22 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Acquire Prospective Package From Tempest Minerals

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

2025-12-22 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Middle West Partners Buys Paul Stuart From Mitsui & Co.

2025-12-22 20:52; UTC

Įsigijimai, susijungimai, perėmimai

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

2025-12-22 20:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-12-22 19:56; UTC

Rinkos pokalbiai

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

2025-12-22 19:49; UTC

Įsigijimai, susijungimai, perėmimai

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

2025-12-22 19:23; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Easing in Early December -- Market Talk

2025-12-22 19:23; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Precious Metals Climb to New Heights -- Market Talk

2025-12-22 18:45; UTC

Rinkos pokalbiai

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

2025-12-22 18:30; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

2025-12-22 18:23; UTC

Įsigijimai, susijungimai, perėmimai

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

2025-12-22 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-22 17:06; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

152.24% į viršų

12 mėnesių prognozė

Vidutinis 10.14 USD  152.24%

Aukščiausias 16 USD

Žemiausias 7 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

13

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

140 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat